Clinical trials
Phase 2 Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Terminated | 7 |
| Withdrawn | 7 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Akcea Therapeutics | 3 |
| Kastle Therapeutics, LLC | 3 |
| Diamyd Medical AB | 2 |
| Johnny Ludvigsson | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| University of Alabama at Birmingham | 2 |
| VIVUS LLC | 2 |
| 89bio, Inc. | 1 |
| Albert Einstein College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 65 |
| Diabetes Mellitus | 21 |
| Glucose Metabolism Disorders | 20 |
| Endocrine System Diseases | 13 |
| Lipid Metabolism Disorders | 12 |
| Diabetes Mellitus, Type 2 | 11 |
| Dyslipidemias | 11 |
| Diabetes Mellitus, Type 1 | 9 |
| Genetic Diseases, Inborn | 8 |
| Hyperlipidemias | 8 |
Trials
Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.